JPMorgan Chase & Co. restated their neutral rating on shares of Bayer AG (FRA:BAYN) in a research note released on Thursday morning.

Analyst Recommendations for Bayer AG (FRA:BAYN)

A number of other equities research analysts have also weighed in on BAYN. Commerzbank AG set a €109.00 ($121.11) price objective on Bayer AG and gave the company a neutral rating in a research note on Thursday, May 19th. Bank of America Corp. set a €105.00 ($116.67) price objective on Bayer AG and gave the company a neutral rating in a research note on Thursday, May 19th. Baader Bank set a €142.00 ($157.78) price objective on Bayer AG and gave the company a neutral rating in a research note on Thursday, May 19th. Warburg Research set a €139.00 ($154.44) price objective on Bayer AG and gave the company a buy rating in a research note on Thursday, May 19th. Finally, Nord/LB set a €124.00 ($137.78) price objective on Bayer AG and gave the company a buy rating in a research note on Thursday, May 19th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have issued a buy rating to the stock. Bayer AG presently has an average rating of Hold and a consensus target price of €112.17 ($124.63).

Shares of Bayer AG (FRA:BAYN) opened at 92.125 on Thursday. The stock has a market cap of €76.18 billion and a PE ratio of 16.919. The stock’s 50 day moving average price is €95.47 and its 200 day moving average price is €95.90. Bayer AG has a 1-year low of €83.87 and a 1-year high of €127.21.

Bayer AG Company Profile

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.